Global X Aging Population ETF(AGNG)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
1-STAR RATING
Consider higher Upturn Star rating
BUY for 21 days
PROFIT SINCE LAST BUY
+0.47% ▲
LAST CLOSE
$38.81
11/20/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for AGNG

11/20/2026: AGNG (1-star) has a low Upturn Star Rating. Not recommended to BUY.

The Global X Aging Population ETF (AGNG) provides targeted exposure to global companies positioned to benefit from the growing senior demographic, spanning pharmaceuticals, medical devices, healthcare services, and senior living facilities. It achieves this via a passive replication strategy tracking the Indxx Aging Population Thematic Index with standard diversification caps. Its primary strengths lie in its pure-play thematic design and global developed market reach, making it a fitting satellite allocation for investors seeking long-term secular growth. Key risks include sector concentration, healthcare regulatory pressures, and moderate liquidity relative to broad-market funds. It is best suited for growth-oriented investors willing to accept sector-specific volatility in exchange for demographic-driven upside.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

ETF holdings, costs, diversification, valuation, risks, and market conditions provide supporting context about the fund.

Investor Fit

Investor styleFitWhy
Growth investorStrong fitSuited for investors looking to capture long-term structural growth driven by global demographic aging trends.
Momentum investorStrong fit while signal remains positiveCan capture strong upward momentum during periods of outperformance in healthcare and biotechnology sectors.
Value investorMixed fitMany constituent holdings trade at elevated valuations given their growth and R&D focus.
Dividend/Income investorMixed fitWhile some holdings pay steady dividends, the fund prioritizes thematic capital appreciation over high current yield.
Low-risk investorWeak fitSubject to sector-specific regulatory, clinical trial, and equity market volatility.

Investor Profile

Ideal Investor Profile

Long-term investors seeking targeted thematic exposure to the secular growth trends arising from global population aging and increased healthcare longevity.

Suitability

Best utilized as a satellite holding within a diversified long-term portfolio rather than a core passive index holding.

Risk Profile

Risk factorLevelWhy it matters
VolatilityMedium / highThematic exposure to healthcare and biotechnology can experience sharp price swings based on sentiment and regulatory updates.
Market riskHighAs an equity fund, it is fully exposed to broad stock market downturns and systemic financial shocks.
ConcentrationMediumConcentrated specifically in industries serving the aging demographic rather than the broader broad-market economy.
Tracking/expenseLowAn expense ratio of 0.50% and effective index replication keep tracking errors minimal.
LiquidityMediumModerate assets under management mean trading blocks should be executed carefully to avoid wider spreads.
Business/sector qualityMedium / highRelies heavily on the fundamental health, regulatory approvals, and financial stability of global healthcare enterprises.

Sector & Industry Intelligence

This fund is not assigned to one sector.

Risk Analysis

Volatility

AGNG demonstrates moderate-to-high historical volatility typical of thematic equity funds that concentrate in growth-oriented healthcare and pharmaceutical sub-sectors.

Market Risk

The fund is subject to risks tied to equity market cycles, healthcare policy changes, clinical trial outcomes, and macroeconomic sentiment affecting growth valuations.

What the ETF Owns

Exposure TypeExposureWeight (%)Retail Investor Read
Single stockEli Lilly and Company (LLY)4.04Provides top-tier exposure to leading pharmaceutical developments addressing age-related chronic conditions.
Single stockAbbVie Inc. (ABBV)3.72Offers diversified exposure to major therapeutics and immunology treatments heavily utilized by older populations.
SectorHealthcare Products, Pharmaceuticals, and Medical Devices55Captures the core medical and therapeutic equipment providers driving longevity and medical advancements.
IndustrySenior Living Facilities and Specialized Real Estate (WELL, VTR)15Provides direct exposure to senior housing and healthcare real estate serving an expanding aging society.
GeographyGlobal Developed Markets (US, Europe, Japan)25.24Ensures broad geographic diversification across advanced economies experiencing rapid demographic aging.

Price Behavior

Steady Uptrend
PRICE PATH

Steady Uptrend

The stock demonstrates consistent and steady upward price momentum.

Very Smooth
PRICE STABILITY

Very Smooth

The stock has followed a highly orderly price path with minimal short-term disruption.

Analysis of Past Performance

Type ETF
Historic Profit 39.6%
Avg. Invested days 85
Today’s Advisory Consider higher Upturn Star rating
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 5.0
ETF Returns Performance Upturn Returns Performance icon 5.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/20/2026
Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.